Literature DB >> 30685870

Early Postnatal IGF-1 and IGFBP-1 Blood Levels in Extremely Preterm Infants: Relationships with Indicators of Placental Insufficiency and with Systemic Inflammation.

Alan Leviton1, Elizabeth N Allred1, Raina N Fichorova2, Deborah K VanderVeen3, T Michael O'Shea4, Karl Kuban5, Olaf Dammann6,7.   

Abstract

OBJECTIVE: To evaluate to what extent indicators of placenta insufficiency are associated with low concentrations of insulin-like growth factor 1 (IGF-1) and IGF-1-binding protein-1 (IGFBP-1) in neonatal blood, and to what extent the concentrations of these growth factors are associated with concentrations of proteins with inflammatory, neurotrophic, or angiogenic properties. STUDY
DESIGN: Using multiplex immunoassays, we measured the concentrations of IGF-1 and IGFBP-1, as well as 25 other proteins in blood spots collected weekly from ≥ 880 infants born before the 28th week of gestation, and sought correlates of concentrations in the top and bottom quartiles for gestational age and day the specimen was collected.
RESULTS: Medically indicated delivery and severe fetal growth restriction (sFGR) were associated with low concentrations of IGF-1 on the first postnatal day and with high concentrations of IGFBP-1 on almost all days. Elevated concentrations of IGF-1 and IGFBP-1 were accompanied by elevated concentrations of many other proteins with inflammatory, neurotrophic, or angiogenic properties.
CONCLUSION: Disorders associated with impaired placenta implantation and sFGR appear to account for a relative paucity of IGF-1 on the first postnatal day. Elevated concentrations of IGF-1 and especially IGFBP-1 were associated with same-day elevated concentrations of inflammatory, neurotrophic, and angiogenic proteins. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30685870      PMCID: PMC7252600          DOI: 10.1055/s-0038-1677472

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  82 in total

1.  Biomarker epidemiology of cerebral palsy.

Authors:  Olaf Dammann; Alan Leviton
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

2.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

Review 3.  Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Luca A Ramenghi; Chatarina Löfqvist; Lois E H Smith; Anna-Lena Hård
Journal:  Am J Perinatol       Date:  2016-09-07       Impact factor: 1.862

Review 4.  Screening for fetal growth restriction and placental insufficiency.

Authors:  Melanie C Audette; John C Kingdom
Journal:  Semin Fetal Neonatal Med       Date:  2017-12-06       Impact factor: 3.926

5.  Systemic responses of preterm newborns with presumed or documented bacteraemia.

Authors:  Alan Leviton; T Michael O'Shea; Francis J Bednarek; Elizabeth N Allred; Raina N Fichorova; Olaf Dammann
Journal:  Acta Paediatr       Date:  2011-12-07       Impact factor: 2.299

6.  Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis.

Authors:  Gary W Hunninghake; Kevin C Doerschug; Amanda B Nymon; Gregory A Schmidt; David K Meyerholz; Alix Ashare
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

7.  Prethreshold retinopathy in premature infants with intrauterine growth restriction.

Authors:  Jennifer W Lee; Deborah VanderVeen; Elizabeth N Allred; Alan Leviton; Olaf Dammann
Journal:  Acta Paediatr       Date:  2014-10-23       Impact factor: 2.299

Review 8.  Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration.

Authors:  Ignacio Herraiz; Elisa Simón; Paula Isabel Gómez-Arriaga; José Manuel Martínez-Moratalla; Antonio García-Burguillo; Elena Ana López Jiménez; Alberto Galindo
Journal:  Int J Mol Sci       Date:  2015-08-13       Impact factor: 5.923

9.  Differential methylation of genes associated with cell adhesion in preeclamptic placentas.

Authors:  Lauren Anton; Amy G Brown; Marisa S Bartolomei; Michal A Elovitz
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

Review 10.  Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Chatarina Löfqvist; Linda van Marter; Mirjam van Weissenbruch; Luca A Ramenghi; Kathryn Beardsall; David Dunger; Anna-Lena Hård; Lois E H Smith
Journal:  Acta Paediatr       Date:  2016-03-08       Impact factor: 2.299

View more
  4 in total

1.  Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.

Authors:  Susanna Klevebro; Gunnel Hellgren; Ingrid Hansen-Pupp; Dirk Wackernagel; Boubou Hallberg; Jan Borg; Aldina Pivodic; Lois Smith; David Ley; Ann Hellström
Journal:  Growth Horm IGF Res       Date:  2019-11-09       Impact factor: 2.372

2.  Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age.

Authors:  Mandy B Belfort; Sara E Ramel; Camilia R Martin; Raina Fichorova; Karl C K Kuban; Timothy Heeren; Rebecca C Fry; T Michael O'Shea
Journal:  J Pediatr       Date:  2021-09-08       Impact factor: 4.406

3.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

Review 4.  Placental programming, perinatal inflammation, and neurodevelopment impairment among those born extremely preterm.

Authors:  Jacqueline T Bangma; Hadley Hartwell; Hudson P Santos; T Michael O'Shea; Rebecca C Fry
Journal:  Pediatr Res       Date:  2020-11-12       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.